小鼠肝脏特异性敲除Tm6sf2促进脂肪变、纤维化及肝癌
研究构建肝脏特异性Tm6sf2敲除小鼠,发现其自发肝脏脂肪变,VLDL甘油三酯分泌减少且颗粒小而脂化不足;高乳脂饮食3周及致纤维化高脂/果糖饮食20周加重脂肪变和纤维化;两种HCC模型中肿瘤负荷和面积增加,AAV8介导的野生型或E167K突变型Tm6回补可减轻表型。
要点
- 肝脏特异性敲除Tm6sf2导致VLDL分泌受损并自发肝脏脂肪变。
- Tm6 LKO小鼠在致纤维化饮食下脂肪变和纤维化加重。
- 两种HCC模型中Tm6 LKO小鼠肿瘤负荷增加,AAV8回补可减轻。
核心结论
- 肝脏特异性Tm6sf2缺失损害VLDL分泌,促进肝脏脂肪变、纤维化并加速HCC发生,AAV8介导的回补可减轻上述表型。
研究设计与样本
- 构建两种独立品系的肝脏特异性Tm6Sf2敲除小鼠(Tm6 LKO),以Tm6 flox小鼠为对照。
- 采用靶向脂质组学、VLDL分泌检测及AAV8血清型8介导的野生型或E167K突变型Tm6回补实验。
- 饮食干预包括高乳脂饮食3周和致纤维化高脂/果糖饮食20周。
- HCC模型包括新生期链脲佐菌素注射联合高脂喂养(NASH/STAM)及二乙基亚硝胺注射联合致纤维化饮食。
主要发现
- 两种独立品系Tm6 LKO小鼠均表现自发肝脏脂肪变。
- 靶向脂质组学显示甘油三酯种类增加,其分布和丰度表型模拟肝脏特异性敲除微粒体甘油三酯转移蛋白小鼠。
- VLDL甘油三酯分泌减少,颗粒小而脂化不足,载脂蛋白B不变或增加。
- AAV8介导的野生型或E167K突变型Tm6回补减少肝脏脂肪变并改善VLDL分泌。
- 高乳脂饮食3周增加脂肪变和纤维化,致纤维化高脂/果糖饮食20周进一步加重表型。
临床怎么用
- 提示TM6SF2功能缺失可能促进NAFLD进展为纤维化和HCC,支持其作为潜在干预靶点。
- AAV8介导的Tm6回补(包括E167K突变型)在模型中减轻表型,为基因治疗策略提供临床前依据。
局限性
- 研究为小鼠模型,结果向人类临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Human transmembrane 6 superfamily 2 (TM6SF2) variant rs58542926 is associated with NAFLD and HCC. However, conflicting reports in germline Tm6sf2 knockout mice suggest no change or decreased very low density lipoprotein (VLDL) secretion and either unchanged or increased hepatic steatosis, with no increased fibrosis. We generated liver-specific Tm6Sf2 knockout mice (Tm6 LKO) to study VLDL secretion and the impact on development and progression of NAFLD. APPROACH AND RESULTS: Two independent lines of Tm6 LKO mice exhibited spontaneous hepatic steatosis. Targeted lipidomic analyses showed increased triglyceride species whose distribution and abundance phenocopied findings in mice with liver-specific deletion of microsomal triglyceride transfer protein. The VLDL triglyceride secretion was reduced with small, underlipidated particles and unchanged or increased apolipoprotein B. Liver-specific adeno-associated viral, serotype 8 (AAV8) rescue using either wild-type or mutant E167K-Tm6 reduced hepatic steatosis and improved VLDL secretion. The Tm6 LKO mice fed a high milk-fat diet for 3 weeks exhibited increased steatosis and fibrosis, and those phenotypes were further exacerbated when mice were fed fibrogenic, high fat/fructose diets for 20 weeks. In two models of HCC, either neonatal mice injected with streptozotocin (NASH/STAM) and high-fat fed or with diethylnitrosamine injection plus fibrogenic diet feeding, Tm6 LKO mice exhibited increased steatosis, greater tumor burden, and increased tumor area versus Tm6 flox controls. Additionally, diethylnitrosamine-injected and fibrogenic diet-fed Tm6 LKO mice administered wild-type Tm6 or E167K-mutant Tm6 AAV8 revealed significant tumor attenuation, with tumor burden inversely correlated with Tm6 protein levels. CONCLUSIONS: Liver-specific Tm6sf2 deletion impairs VLDL secretion, promoting hepatic steatosis, fibrosis, and accelerated development of HCC, which was mitigated with AAV8- mediated rescue.
引用
- Newberry EP, Hall Z, Xie Y, et al. Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer. Hepatology. 2021. PMID: 33638902. doi:10.1002/hep.31771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。